These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7027681)

  • 1. [Lonazolac-Ca-a non-steroidal antirheumatic agent. Long-term clinical study in chronic polyarthritis].
    Lonauer G; Wagner H; Boerngen U; Goebel KM
    Z Rheumatol; 1981; 40(4):161-4. PubMed ID: 7027681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lonazolac-Calcium. A new non-steroidal antirheumatic agent for the treatment of progressive polyarthritis. A long-term open controlled trial].
    Pavelka K
    Fysiatr Revmatol Vestn; 1984 Apr; 62(2):80-7. PubMed ID: 6378745
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lonazolac - a new non-steroidal antirheumatic agent. Report of a double-blind crossover clinical study].
    Trnavský K; Bosmanský K
    Fysiatr Revmatol Vestn; 1983 Jun; 61(3):147-52. PubMed ID: 6350135
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term study with lonazolac-Ca in activated arthrosis and chronic polyarthritis].
    Bröll H; Tausch G
    MMW Munch Med Wochenschr; 1982 Aug; 124(34):737-8. PubMed ID: 6813698
    [No Abstract]   [Full Text] [Related]  

  • 5. [Double-blind comparative trial of lonazolac-Ca versus naproxen in spinal osteoarthrosis, coxarthrosis and gonarthrosis (author's transl)].
    Siegmeth W; Placheta P
    Wien Klin Wochenschr; 1982 Mar; 94(6):145-7. PubMed ID: 7048748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Action of the anti-inflammatory agent Lonazolac on experimentally-induced acute inflammation of human skin].
    Dethlefs J
    Z Rheumatol; 1978; 37(7-8):254-9. PubMed ID: 358658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preventing postoperative edema with Irritren. Results of a double-blind study].
    Biehl G
    Fortschr Med; 1981 May; 99(19):745-8. PubMed ID: 7239397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics of the antirheumatic lonazolac-Ca in humans].
    Huber R; Zech K; Dittmann EC; Lühmann R; Petitet A
    Arzneimittelforschung; 1990 Aug; 40(8):918-25. PubMed ID: 2242085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of a long-term study with acemetacin in the therapy of patients suffering from rheumatoid arthritis (author's transl)].
    Heiter A; Tausch G; Eberl R
    Arzneimittelforschung; 1980; 30(8A):1460-3. PubMed ID: 7191319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinico-therapeutic experiences with a new anti-inflammatory agent: DA 2370].
    Scanni A; Ferrari P
    Minerva Med; 1973 Oct; 64(71):3718-24. PubMed ID: 4588363
    [No Abstract]   [Full Text] [Related]  

  • 11. [Double blind cross-over study with lonazolac-Ca and diclofenac-Na in 30 patients with chronic polyarthritis].
    Vetter G; Abele I
    ZFA (Stuttgart); 1981 Dec; 57(35-36):2451-6. PubMed ID: 7324561
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience.
    Yocum DE; Furst DE; Bensen WG; Burch FX; Borton MA; Mengle-Gaw LJ; Schwartz BD; Wisememandle W; Mekki QA;
    Rheumatology (Oxford); 2004 Aug; 43(8):992-9. PubMed ID: 15014199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gastroduodenal tolerance and clinical effectiveness of therapy with lonazolac-calcium in rheumatic diseases].
    Kullich W; Fromme K; Klein G
    Wien Med Wochenschr; 1996; 146(17):459-64. PubMed ID: 9045528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary results with a new non-steroidal antirheumatic drug (author's transl)].
    Frank O; Klicpera M; Kolarz G; Scherak O
    Wien Klin Wochenschr; 1975 Jun; 87(13):427. PubMed ID: 779281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transsynovial kinetics of lonazolac and its hydroxy metabolite in synovitis patients.
    Deneke J; Luckow V; Guserle R; Pässler HH
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):418-24. PubMed ID: 9726694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with lonazolac-calcium in the treatment of osteo-arthritis.
    Dijs H; Verheyen G; Guastavino V; De Vroey T; Deckers K; Driessens M
    Acta Belg Med Phys; 1990; 13(4):213-5. PubMed ID: 2097865
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical study of a new anti-inflammatory drug: 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
    Dotti F; Ongari R; Carazzi R; Chierichetti S
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:265-8. PubMed ID: 4553235
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lonazolac-Ca in rheumatic diseases. Studies on its therapeutic effectiveness].
    Nobbe-Balogh S; Frenger W
    ZFA (Stuttgart); 1983 Jan; 59(2):96-100. PubMed ID: 6829215
    [No Abstract]   [Full Text] [Related]  

  • 19. [A comparative gastroscopic study of lonazolac and indomethacin in healthy subjects].
    Müller P; Dammann HG; Simon B
    Arzneimittelforschung; 1986 Sep; 36(9):1399-400. PubMed ID: 3539127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of glucocorticoids in rheumatoid arthritis].
    Jacobsen S
    Ugeskr Laeger; 2000 Feb; 162(6):770-2. PubMed ID: 10689949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.